Clinical Professor, Obstetrics, Gynecology, and Reproductive Sciences, UCSF
Co-Leader, Gynecologic Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center
| CONTACT | |
|
(415) 353-9600 (appts) Box 1702, UCSF; San Francisco, CA 94143-1702 |
additional websites: |
| EDUCATION | |
|
Vassar College, Poughkeepsie, NY, 1972-1976, Honors
|
|
| PROFESSIONAL EXPERIENCE | |
|
1977-1981 |
Director, Norman Bethune People's Health Center, Philadelphia, PA |
|
1986-1987 |
Instructor, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA |
|
1987-1988 |
Director of Outpatient Services, Department of Obstetrics and Gynecology, UCLA, Olive View Medical Center, Los Angeles, CA |
|
1987-1988 |
Assistant Professor, Department of Obstetrics and Gynecology, UCLA, Olive View Medical Center, Los Angeles, CA |
|
1995-1999 |
Director, Division of Gynecologic Oncology, University of California San Francisco |
|
1999-2003 |
Associate Professor, Department of Obstetrics and Gynecology, University of California San Francisco |
|
2001-2007 |
Director, Clinical Gynecologic Oncology, University of California San Francisco |
|
2003-2007 |
Acting Division Chief, Department of Obstetrics and Gynecology, University of California San Francisco |
|
2003-present |
Professor, Department of Obstetrics and Gynecology, University of California San Francisco |
| HONORS & AWARDS | |
|
2005 - present |
Best Doctor's in America |
|
2003 |
Best Bay Area Doctors, San Francisco Focus |
|
1997 - 2000 |
Mount Zion Foundation Award - Development of Gyn/Oncologic Group Clinical Research |
|
1998 |
Mount Zion Foundation Award Use of medicinal herbs in Ovarian Cancer |
|
1992 - 1995 |
American Cancer Society Clinical Oncology Career Development Award Tumor necrosis factor in ovarian cancer |
|
1992 - 1995 |
Irwin Foundation Award |
|
1991 |
Affirmative Action Research Award |
|
1991 |
Society of Gynecologic Oncologists Foundation Award |
|
1980 |
AMSA Award Lecture, Establishment of a Community Health Center, University of Maryland School of Medicine |
|
1978 |
Albert Einstein School of Medicine -- 1978 Family Practice Symposia "Community Health in the '80s" |
| SELECTED PUBLICATIONS | |
|
JM Lancaster, CB Powell, ND Kauff, I Cass, LM Chen, KH Lu, DG Mutch, A Berchuck, BY Karlan, TJ Herzog. Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions. Gynecol Oncol. 2007 Nov;107(2):159-162 | |
|
Suh-Burgmann E, Powell CB Cytoreductive surgery for gynecologic malignancies-new standards of care. Surg Oncol Clin N Am. 2007 Jul;16(3):667-82. | |
|
Yang K, Allen B, Conrad P, Powell CB, Terdiman J, Chen LM. Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families. Fam Cancer. 2006;5(4):405-9. Epub 2006 Aug 26. | |
|
Powell CB Occult ovarian cancer at the time of risk-reducing salpingo-oophorectomy. Gynecol Oncol. 2006 Jan;100(1):1-2. | |
|
Qayyum A, Coakley FV, Westphalen AC, Hricak H, Okuno WT, Powell B. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol. 2005 Feb;96(2):301-306. | |
|
Powell CB, Kenley E, Chen LM, Crawford B, McLennan J, Zaloudek C, Komaromy M, Beattie M, Ziegler J. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J Clin Oncol. 2005 Jan 1;23(1):127-32. | |
|
Chen L, Learman LA, Weinberg V, Powell CB. Discordance between beliefs and recommendations of gynecologic oncologists in ovarian cancer management. Int J Gynecol Cancer. 2004 Nov-Dec;14(6):1055-62. | |
|
Chen L, Lengyel ER, Powell CB. Single agent pulse dactinomycin has only modest activity for methotrexate resistant gestational trophoblastic neoplasia. Gynecol Oncol 2004; 94: 204-207. | |
|
Powell CB, Fung F, Jackson J, Dall'Era J, Lewkowicz D, Cohen I, Smith-McCune K. Aqueous extract of herba Scutellaria barbatae, a Chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines. Gynecol Oncol. 2003 Nov;91(2):332-40. | |
|
Powell CB, Dibble SL, Dall'Era JE, Cohen I. Use of herbs in women diagnosed with ovarian cancer. Int J Gynecol Cancer. 2002 Mar-Apr;12(2):214-7. | |
|
Dudley, RA, Hricak, H, Scheidler, J, Yu, K, Kahlben, C, Powell, CB, Schwartz, L, Yetter, EM, OUMalley, CM, Warren, R. Shared Patient Analysis: A Method to Assess the Clinical Benefits of Patient Referrals. Medical Care, 2001; 39(11): 1182-7. | |
|
Suzuki S, Moore DH 2nd, Ginzinger DG, Godfrey TE, Barclay J, Powell B, Pinkel D, Zaloudek C, Lu K, Mills G, Berchuck A, Gray JW. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res. 2000 Oct 1;60(19):5382-5. | |
|
Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell CB, Mills GB, Gray JW. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet. 1999 Jan;21(1):99-102. | |
|
Kinkel K, Yu KK, Kaji Y, Segal MR., Powell CB, Hricak H. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology. 1999 Sep;212(3):711-8. | |
|
Hricak H, Chen M, Coakley FV, Kinkel K, Yu KK, Sica G, Bacchetti P, Powell CB. Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis. Radiology. 2000 Jan;214(1):39-46. | |
|
Powell CB, Scott JH, Collins JL. Comparison of TNFalpha and TNFbeta cytolytic mechanisms in human ovarian and cervical carcinoma cell lines. Gynecol Oncol. 1998 Nov;71(2):258-65. | |
|
Swift PS, Purser P, Roberts LW, Pickett B, Powell CB, Phillips T. Pulsed low-dose-rate brachytherapy for pelvic malignancies. International Journal of Radiation Oncology, Biology, Physics 37 (4): 811-7, 1997. | |
|
Zaloudek C, Hayashi GM, Ryan IP, Powell CB, Miller TR. Microglandular adenocarcinoma of the endometrium: A form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix. Int. Jour. of Gyn. Path. 16:52-59, 1997. | |
|
Hricak H, Yu KK, Powell CB, Subak LL, Stern J, Arenson RL. Comparison of diagnostic studies in the pre-treatment evaluation of stage Ib carcinoma of the cervix. Acad. Radiol., 3 Suppl 1(7) S44-6, 1996. | |
|
Zaloudek, C., M.D., Teseler P.A., M.D.,Ph.D., Powell, C.B.: Postarthroplasty Histiocytic Lymphadenopathy in Gynecologic Oncology Patients. American Cancer Society, 79(4)834-44. | |
|
Powell CB, Scott JH, Collins JL. Characterization of the protein synthesis independent TNFalpha lytic mechanism in human ovarian and cervical carcinoma cell lines. Gynecol Oncol. 1996 Jul;62(1):42-8. | |
|
Hricak, H.; Powell C.B.; Yu, K.K.; Washington, E.; Subak, L.L.; Stern, J.; Cisternas, M.G.and Arenson, R.: Invasive cervical carcinoma: the role of MRI in pre-treatment work-up: cost minimization and diagnostic efficacy analysis. Radiology. 198:403-9, 1996. | |
|
Zaloudek, C.; Treseler, P.A. and Powell, C.B.: Post-arthroplasty histiocytic lymphadenopathy in gynecologic oncology patients: A benign Reactive process often mistaken clinically for cancer. Cancer, 78(4):834-44, 1996. | |
|
Hricak H, Yu KK, Powell CB, Subak LL, Stern J, Arenson RL: Comparison of diagnostic studies in the pre-treatment evaluation of stage Ib carcinoma of the cervix. Acad Radiol: 3 Suppl 1(7) S44-46, 1996. | |
|
Forstner, R.; Hricak, H.; Occhipinti, K.; Powell CB, and Stern, J.L. Ovarian cancer: staging with of CT and MR imaging. Radiol. 197(3): 619-26, 1995. | |
|
Subak, L.L.; Hricak, H.; Powell CB, Azizi, L.and Stern, J.L.: Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstetrics and Gynecology 86(1):43-50, 1995. | |
|
Forstner, R.; Hricak, H.; Powell CB, Azizi, L.; Frankel, S.B.and Stern, J.L.: Ovarian cancer recurrence: value of MR imaging. Radiol. 196(3):715-20, 1995. | |
|
Powell CB, Herzog, T.J.; Scott, J.H. and Collins, J.L.: Evidence for a protein synthesis dependent and independent TNFacytolytic mechanism. Gyn. Onc. 58(3):327-35, 1995. | |
|
Powell CB, Horuchi,T.; Mutch, D.G.; Kao, M.S. and Collins, J.L.: Interferon alpha (IFNa) activates a lytic mechanism in ovarian and cervical carcinoma cells AJOG 169:661-667, 1993 | |
|
Powell CB, Manning, K.M. and Collins, J.L.: Interferon a (IFNa) induces a cytolytic mechanism in ovarian carcinoma cells through a protein kinase C dependent pathway. Gyn. Onc. 50:208-214, l993. | |
|
Mutch, D.G.; Powell CB, Kao, M.S. and Collins, J.L.: Resistance to cytolysis by TNF-alpha in malignant gynecologic cell lines is associated with the expression of proteins that prevent the activation of phospholipase A2 by TNFa. Cancer Research 52:866-872, 1992. | |
|
Massad, L.S.; Mutch, D.G.; Powell CB, Kao, M.S. and Collins, J. L.: Inhibition of protein synthesis enhances lyric effects of tumor necrosis factor a and interferon g in cell lines derived from gynecologic malignancies. Cancer Immunol. Immunother. 33:183-188, 1991. | |
|
Powell CB, Sedlacek, T.V.; Riva, J. and Mangan, C.E.: Multicentricity of HPV infections in the lower genital tract. J. Gyn. Surg. 6:39-42, 1990. | |
|
Powell CB, Mutch, D.G.; Kao, M.S. and Collins, J.L.: Dexamethasone used as an anti-emetic in chemotherapy protocols inhibits natural cytotoxic (NC) activity. Cancer 65:466-472, 1990. | |
|
Powell CB, Mutch, D.G.; Kao, M.S. and Collins, J.L.: Reduced natural cytotoxic (NC) cell activity in patients receiving cisplatin based chemotherapy. Clin. Exp. Immunol. 79:424429, 1990. | |
|
Massad, L.S.; Mutch, D.G.; Powell CB, Kao, M.S. and Collins, J.L.: Expression of a resistance mechanism in ovarian and cervical carcinoma cells prevents their lysis by interferon gamma. Cancer Res. 50(4923-28), 1990. | |
|
Powell CB, Mutch, D.G.; Massad, L.S.; Kao, M.S. and Collins, J.L.: Common expression of a protein synthesis dependent resistance mechanism that prevents lysis by tumor necrosis factor alpha among carcinoma cell lines derived from gynecologic malignancies. Cancer Immunol. Immunother. 32(131-36), 1990. | |
|
Mutch, D.G.; Powell, C.B. and Collins, J.L.: In vitro analysis of the anti-cancer potential of tumor necrosis factor (TNF) in combination with cisplatin. Gyn. Onc. 34:328-333, 1989. | |
|
Powell CB, Cunane, M. and Corson, S.: Leiomyoma associated with Rokitansky's Syndrome. J. Reprod. Med. 33:493-494, 1988. | |
|
Powell, C.B.: Community Health in the '80s. Family Practice Symposia, Albert Einstein School of Medicine, 1978. |
|
|
1/31/08 |
|


